Table of Content

1 Market Introduction
1.1 Market Definition
1.2 Research Scope and Segmentation
1.3 Stakeholders
1.4 List of Abbreviations


2 Executive Summary


3 Research Methodology
3.1 Identification of Data
3.2 Data Analysis
3.3 Verification
3.4 Data Sources
3.5 Assumptions


4 Market Dynamics
4.1 Market Drivers
4.2 Market Restraints
4.3 Market Opportunities
4.4 Market Challenges


5 Porter’s Five Force Analysis
5.1 Bargaining Power of Suppliers
5.2 Bargaining Power of Buyers
5.3 Threat of New Entrants
5.4 Threat of Substitutes
5.5 Competitive Rivalry in the Market


6 Global Monoclonal Antibody Therapeutics Market by, Source
6.1 Overview
6.2 Human
6.3 Humanized
6.4 Chimeric
6.5 Other Sources


7 Global Monoclonal Antibody Therapeutics Market by, Therapy Area
7.1 Overview
7.2 Autoimmune & Inflammatory Disorders
7.3 Oncology
7.4 Hematology
7.5 Ophthalmology
7.6 Other Therapy Areas


8 Global Monoclonal Antibody Therapeutics Market by, Route of Administration
8.1 Overview
8.2 Intravenous
8.3 Subcutaneous
8.4 Other Route of Administrations


9 Global Monoclonal Antibody Therapeutics Market by, Production Method
9.1 Overview
9.2 In-Vitro
9.3 In-Vivo


10 Global Monoclonal Antibody Therapeutics Market by, End User
10.1 Overview
10.2 Hospitals
10.3 Long-term Care Facilities
10.4 Other End Users


11 Global Monoclonal Antibody Therapeutics Market by, Geography
11.1 Overview
11.2 North America
11.2.1 US
11.2.2 Canada
11.2.3 Mexico
11.3 Europe
11.3.1 Germany
11.3.2 France
11.3.3 UK
11.3.4 Italy
11.3.5 Spain
11.3.6 Rest of Europe
11.4 Asia Pacific
11.4.1 China
11.4.2 Japan
11.4.3 India
11.4.4 South Korea
11.4.5 Australia
11.4.6 New Zealand
11.4.7 Rest of Asia Pacific
11.5 South America
11.5.1 Brazil
11.5.2 Argentina
11.5.3 Chile
11.5.4 Rest of South America
11.6 Middle East & Africa
11.6.1 UAE
11.6.2 Saudi Arabia
11.6.3 Qatar
11.6.4 Iran
11.6.5 South Africa
11.6.6 Rest of Middle East & Africa


12 Key Developments


13 Company Profiling
13.1 Abbvie Inc
13.1.1 Business Overview
13.1.2 Product/Service Offering
13.1.3 Financial Overview
13.1.4 SWOT Analysis
13.1.5 Key Activities
13.2 Amgen Inc.
13.3 AstraZeneca
13.4 Biogen
13.5 Bristol Myers Squibb Company
13.6 Eli Lilly and Company
13.7 F. Hoffmann-La Roche Ltd
13.8 Johnson & Johnson Services, Inc
13.9 Merck & Co., Inc
13.10 Novartis AG
13.11 Sanofi
13.12 UCB S.A